ReleaseWire Connect

Biorationals are insecticides effective against the target pest, but less harmful to natural enemies. These products are obtained from the natural sources such as plant extracts and pathogens. The biorational products are widely used in structural pest control, agriculture, public health, forestry, turf, aquaculture, and home and garden. In addition, biorational products are typically derived from natural as well as biological methods. Moreover, rise in usage of environmental pest control technologies help the end users achieve agriculture sustainability and it maximizes the quality of crops. Furthermore, green crop protection initiative in the European region has motivated the bio rational producers to develop eco-friendly solutions and products for consumers in the agriculture industry.

Agricultural biologicals are topical or seed treatment products made from natural materials, which are majorly used to replace chemicals used in agriculture farming. These biologicals are used to protect crops from pests, weeds, and diseases, thereby maintaining crops healthy. In addition, farmers are dependent upon agricultural biologicals as it discourages the use of synthetic and chemical fertilizers to grow healthy and nutritious food.

Oil & Gas accumulators are hydro-pneumatic equipment, which can store non-compressible fluid even under extreme pressure. The fluid is stored via an external source that can either be piston, spring, gas and fluid. Furthermore, oil accumulators are used for different purposes, including noise reduction as well as pulsation dampening. These accumulators are available in different shapes. Most popular types of oil and gas accumulators are diaphragm, bladder and piston.

Obesity is a medical term used when excessive accumulation of fat occurs in the body. It may have numerous adverse effects on health, which increases the chances of occurrence of diseases and ultimately reduces life expectancy of an individual. Some of the diseases to which an obese individual is prone include type II diabetes, heart diseases, osteoarthritis and even certain types of cancer. One-third of adults in the U.S are obese. The rising pace of obesity and chronic diseases is creating the need for weight loss programs and obesity management. The increase in heath concern, high disposable income and technological advancements are driving the growth of Weight Loss and Obesity Market. The availability of low cost substitutes and expensive customization is limiting the growth of this market. The increasing rate of obesity among children provides significant opportunities for growth of this market.

Oral Proteins and Peptides Market are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability and sensitivity towards body fluids. Oral route of administration is very convenient route; however, the bioavailability of proteins and peptides is less, when administered orally due to degradation of amino acids in gastrointestinal tract. With the advancement in technology formulation containing protein and peptides are introduced in the market that can be orally administered with no change in therapeutic activity and pharmacokinetic aspects.

Erectile dysfunction Market is also termed as impotence and it is characterized by incapability to build up or sustain a penile erection during sexual intercourse. An Erection of penis involves hydraulic effect resulting from entry and retention of blood into spongy bodies within penis. Sexual arousal is responsible for initiation of this process which is signalized by impulse mechanism from brain to penile nerves. The causes of erectile dysfunction involve side effects of drugs, Cavernosal disorders, Neurogenic disorders, Aging, Psychological causes, Multiple sclerosis and Diabetes, and Lifestyle modifications. Pin-point analysis of global erectile dysfunction drugs market focuses on various aspects of market such as, market trends, market drivers, restrains and opportunities. Competitive landscape section focuses on key leaders within global erectile dysfunction drugs market and their major growth strategies. Deep-dive assessment of segments identifies the potential segment which would act as guide to strategist.

The factors propelling the growth of the Automotive Camera Market are growing influence of new car assessment program (NCAP), increasing demand for luxury vehicles, and demand for safety measures. However, high cost of advanced driver assistance systems (ADAS) hinders the growth of the market. Supportive government policies and growing trend of installing ADAS in passenger cars create opportunities for growth.

The factors that are driving the demand for Automotive Night Vision System Market are increasing demand for luxurious cars in developing market, increasing safety concerns in consumers and use of advanced technologies to get competitive advantage. The increasing price trend in the ANVS is one of the major challenge, as the technologies used in ANVS such as sensitivity and resolution cost high. However, it is expected that there will be a remarkable growth in the demand of ANVS from 2014 to 2020.

Increased safety awareness, technological advancement and the need for safety measures are driving the growth of the Automotive Telematics Market. Also, government regulations regarding accidents and safety of road transportation are supporting the growth of this market. However, high error rates and breakdown in communication are challenges for this market. Since 2007, a double digit growth in Fleet has opened up the opportunities for the market. Vehicle makers are also offering better opportunities for the market, as they continue to develop smart cars that use telematics technology to deliver better results for customers.

According to a new report published by Allied Market Research, titled, Intravenous Therapy and Vein Access Devices Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global intravenous therapy and vein access devices market was valued at $18,000 million in 2016, and is projected to reach $27,971 million by 2023, growing at a CAGR of 6.4% from 2017 to 2023. The intravenous catheter segment accounted for a one-third share of the total market in 2016.